Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab

Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab

Submitted by admin on January 9, 2023 - 10:34am
Source: 
Fierce Biotech
News Tags: 
Voyager Therapeutics
Neurocrine
capsids
CNS
Parkinson's Disease
Headline: 
Neurocrine blows fresh wind in Voyager's sails with $175M upfront for CNS capsid collab
snippet: 

Voyager Therapeutics’ bet on its capsid technology continues to pay off as the company banks $175 million from a strengthened collaboration with long-term partner Neurocrine Biosciences.

Do Not Allow Advertisers to Use My Personal information